£103.74

Humana Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

36351038

Price data last checked 72 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£104 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£103.88 £103.73 £103.76 £103.79 £103.83 £103.86 £103.89 14 April 2026 18 April 2026 23 April 2026 27 April 2026 02 May 2026

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £104 Days at Price

Price Analysis

Most common price: £104 (19 days, 100.0%)

Price range: £104 - £104

Price levels: 1 different prices over 19 days

Description

This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
28 January 2013
Listed Since
23 August 2012

Barcode

No barcode data available

Similar Products You Might Like

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States

£520.00 13 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 13 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 04 Jul 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
97% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India

£515.00 19 Jun 2026
Humana Lymphoma: Diagnosis and Treatment - Clinical Oncology 43
97% match

Humana Lymphoma: Diagnosis and Treatment - Clinical Oncology 43

Humana

£141.51 20 May 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 13 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 17 Jun 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
97% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe
97% match

Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe

£60.24 12 May 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
97% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 18 Jun 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£65.59 08 Jul 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 14 Jun 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£96.52 11 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 18 Jun 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 20 Jun 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments
96% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments

Out of stock 10 Jun 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 21 Jun 2026
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
96% match

The 2025-2030 World Outlook for Non-Hodgkin Lymphoma

£790.00 13 Jun 2026
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
96% match

The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments

£790.00 18 Jun 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.37 09 Jul 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments for US Zip Codes

£490.00 24 Jun 2026
Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book
96% match

Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book

Springer

£46.26 15 May 2026
The 2023 Report on Non-Hodgkin Lymphoma Treatments: World Market Segmentation by City
96% match

The 2023 Report on Non-Hodgkin Lymphoma Treatments: World Market Segmentation by City

£795.00 13 Jun 2026